Steven B. Kanner
Publications by Year
Research Areas
Cancer, Hypoxia, and Metabolism, CAR-T cell therapy research, Cancer Research and Treatments, RNA modifications and cancer, T-cell and B-cell Immunology
Most-Cited Works
- → An Epithelial–Mesenchymal Transition Gene Signature Predicts Resistance to EGFR and PI3K Inhibitors and Identifies Axl as a Therapeutic Target for Overcoming EGFR Inhibitor Resistance(2012)1,115 cited
- → RNAi-based treatment of chronically infected patients and chimpanzees reveals that integrated hepatitis B virus DNA is a source of HBsAg(2017)480 cited
- → A Role for CD5 in TCR-Mediated Signal Transduction and Thymocyte Selection(1995)449 cited
- → Identification and characterization of a novel cytoskeleton-associated pp60src substrate.(1991)434 cited
- → Wiskott-Aldrich Syndrome/X-Linked Thrombocytopenia: WASP Gene Mutations, Protein Expression, and Phenotype(1997)250 cited
- → CD5 Negatively Regulates the T-Cell Antigen Receptor Signal Transduction Pathway: Involvement of SH2-Containing Phosphotyrosine Phosphatase SHP-1(1999)205 cited
- → Filamin Binds to the Cytoplasmic Domain of the β1-Integrin(1998)188 cited
- → Beta 2-integrin LFA-1 signaling through phospholipase C-gamma 1 activation.(1993)184 cited
- → Stable Association of Activated pp60 src with Two Tyrosine-Phosphorylated Cellular Proteins(1989)168 cited
- → Epigenetic Drug Discovery: Targeting DNA Methyltransferases(2011)156 cited